Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia.
PLOS ONE; http://dx.doi.org/10.1371/journal.pone.0164953.
Inactivation of Prions and Amyloid Seeds with Hypochlorous Acid.
Plos.org; http://dx.doi.org/10.1371/journal.ppat.1005914.
miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer's disease.
Biochemical and Biophysical Research Communications; doi: 10.1016/j.bbrc.2016.08.037.
Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3.
US National Library of Medicine; 10.1126/science.aah3374.
Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke.
BMC Neurology; doi: 10.1186/s12883-017-0945-8.
On-chip microtubule gliding assay for parallel measurement of tau protein species.
Lab Chip; doi: 10.1039/c5lc01486g.
Electrochemical detection of anti-tau antibodies binding to tau protein and inhibition of GSK-3β-catalyzed phosphorylation.
Analytical Biochemistry; doi: 10.1016/j.ab.2015.12.002.
Rifampicin is a candidate preventive medicine against amyloid β and tau oligomers.
Oxford University Press; DOI: http://dx.doi.org/10.1093/brain/aww042.
Tau protein, a biomarker of Alzheimer´s disease: in vitro phosphorylation and tau-reactive antibodies characterization.
Charles University; DOI 10.1002/jssc.201501045.
Depletion of microglia and inhibition of exosome synthesis halt tau propagation.
Nature; doi:10.1038/nn.4132.